The retinoic acid paradox in cancer chemoprevention
- PMID: 16595769
- DOI: 10.1093/jnci/djj116
The retinoic acid paradox in cancer chemoprevention
Comment on
-
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.J Natl Cancer Inst. 2006 Apr 5;98(7):441-50. doi: 10.1093/jnci/djj091. J Natl Cancer Inst. 2006. PMID: 16595780 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical